Scribe Therapeutics becomes latest CRISPR company to announce layoffs

CRISPR biotech Intellia cuts staff as it eyes 2027 launch

Eyeing a first commercial launch in 2027, Intellia is re-prioritising by cutting 27% of its workforce and shelving a lung disease candidate.

Burlington-based security firm announces layoffs

Security unicorn reportedly lays off 'dozens'

Scribe Therapeutics becomes latest CRISPR company to announce layoffs

Co-founded by Jennifer Doudna, Scribe will lose 20% of its staff as it moves toward clinical trials with its CasX gene editor.

Gene editing startup Scribe Therapeutics cuts staff as it preps for the clinic

Scribe Therapeutics, a biotech co-founded by CRISPR pioneer Jennifer Doudna, is reducing its workforce by about 20%, the company confirmed to Endpoints News. CEO Ben Oakes told Endpoints by phone Wednesday morning that the move ...